Literature DB >> 11549562

Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy.

N A Hessol1, M Schneider, R M Greenblatt, M Bacon, Y Barranday, S Holman, E Robison, C Williams, M Cohen, K Weber.   

Abstract

Even though women and people of color represent an increasing proportion of US acquired immunodeficiency syndrome (AIDS) cases, few research studies include adequate representation of these populations. Here the authors describe recruitment and retention of a diverse group of human immunodeficiency virus (HIV)-infected and at risk HIV-uninfected women in a prospective study operating in six sites across the United States. Methods used to minimize loss to follow-up in this cohort are also described. For the first 10 study visits that occurred during a 5-year period between 1994 and 1999, the retention rate of participants was approximately 82%. In adjusted Cox analysis, factors associated with retention among all women were older age, African-American race, stable housing, HIV-infected serostatus, past experience in studies of HIV/AIDS, and site of enrollment. In an adjusted Cox analysis of HIV-infected women, African-American race, past experience in studies of HIV/AIDS, site of enrollment, and reported use of combination or highly active antiretroviral HIV therapy at the last visit were significantly associated with retention. In adjusted Cox analysis of HIV-uninfected study participants, only the site of enrollment was significantly associated with study retention. These results show that women with and at risk for HIV infection, especially African-American women, can be successfully recruited and retained in prospective studies.

Entities:  

Mesh:

Year:  2001        PMID: 11549562     DOI: 10.1093/aje/154.6.563

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  61 in total

1.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

2.  Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.

Authors:  Nancy A Hessol; Susan Holman; Howard Minkoff; Mardge H Cohen; Elizabeth T Golub; Seble Kassaye; Roksana Karim; Oluwakemi Sosanya; Christopher Shaheen; Zaher Merhi
Journal:  AIDS Care       Date:  2015-08-14

Review 3.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 4.  Increasing minority research participation through community organization outreach.

Authors:  Roger A Alvarez; Elias Vasquez; Carla C Mayorga; Daniel J Feaster; Victoria B Mitrani
Journal:  West J Nurs Res       Date:  2006-08       Impact factor: 1.967

5.  Recruiting minority men who have sex with men for HIV research: results from a 4-city campaign.

Authors:  Anthony J Silvestre; John B Hylton; Lisette M Johnson; Carmoncelia Houston; Mallory Witt; Lisa Jacobson; David Ostrow
Journal:  Am J Public Health       Date:  2006-05-02       Impact factor: 9.308

6.  Eligibility, recruitment, and retention of African Americans with severe mental illness in community research.

Authors:  Michelle DeCoux Hampton; Mary C White; Linda Chafetz
Journal:  Community Ment Health J       Date:  2008-11-11

7.  Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.

Authors:  S J Gange; Y Barrón; R M Greenblatt; K Anastos; H Minkoff; M Young; A Kovacs; M Cohen; W A Meyer; A Muñoz
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

8.  Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.

Authors:  Audrey L French; Anna Hotton; Mary Young; Marek Nowicki; Michael Augenbraun; Kathryn Anastos; Eric Seaberg; William Rosenberg; Marion G Peters
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

9.  Successful techniques for retaining a cohort of infants and children born to HIV-infected women: the prospective P2C2 HIV study.

Authors:  Kimberly Geromanos; Susan N Sunkle; Mary Beth Mauer; Diane Carp; Jessica Ancker; Weihong Zhang; Kirk A Easley; Mark D Schluchter; Claudia A Kozinetz; Robert B Mellins
Journal:  J Assoc Nurses AIDS Care       Date:  2004 Jul-Aug       Impact factor: 1.354

10.  Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States.

Authors:  Nancy A Hessol; Kathleen M Weber; Susan Holman; Esther Robison; Lakshmi Goparaju; Christine B Alden; Naoko Kono; D Heather Watts; Niloufar Ameli
Journal:  J Womens Health (Larchmt)       Date:  2009-10       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.